Zidovudine triphosphate mimics

Drug Profile

Zidovudine triphosphate mimics

Alternative Names: Azidothymidine mimics; Azidothymidine triphosphate mimics; AZT-mimics; B-108; B-200; B-446; Zidovudine mimics

Latest Information Update: 26 Mar 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Biota Inc
  • Class
  • Mechanism of Action DNA-directed DNA polymerase inhibitors; Nucleotide reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Bacterial infections; HIV infections

Most Recent Events

  • 26 Mar 2007 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
  • 26 Mar 2007 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
  • 31 May 2004 Data presented at the 17th International Conference on Antiviral Research (ICAR-2004) have been added to the Viral Infections antimicrobial activity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top